| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $7.6M | +16.9% |
| SG&A Expense | $2.9M | +11.8% |
| Operating Income | -$10.5M | -15.4% |
| Income Tax | $0 | — |
| Net Income | -$10.5M | -15.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.2M | -59.7% |
| Current Assets | $13.2M | -35.8% |
| Total Assets | $13.2M | -35.5% |
| Current Liabilities | $3.1M | +98.0% |
| Total Liabilities | $3.1M | +98.5% |
| Stockholders' Equity | $10.1M | -46.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.2M | -198.8% |
| Investing Cash Flow | -$4.9M | — |
| Financing Cash Flow | $33K | -99.7% |